ALPHA-PINENE ATTENUATES MICROGLIAL NF-ΚB ACTIVATION AND INOS EXPRESSION IN GP120-INDUCED NEUROINFLAMMATION
DOI:
https://doi.org/10.21776/ub.mnj.2021.007.01.16Keywords:
apoptosis, gp120, iNOS, neuroinflammation, NF-kBAbstract
Background: Neuro-inflammation plays a role in the pathogenesis of HIV-associated dementia (HIV). Activation of microglia is essential for triggering inflammatory-mediated neurotoxicity. HIV-1 120 kDa envelope glycoprotein (gp120) induces microglial NF-κB signaling which in turn induce pro-inflammatory and iNOS gene transcription. Continuous or excessive activation of NF-κB signaling lead to persistent production of TNF-α and nitric oxide by microglia and induce neuronal apoptosis. Alpha-pinene is a natural substance found in pine tree and has efficacy on inhibiting NF-κB signaling.
Objective: This study was designed as a true experimental study and aimed to investigate the effect of alpha-pinene administration toward inflammatory response represented by the percentage of microglia containing activated NF-κB and iNOS expression.
Methods: Neuron-glia primary culture from brain tissue of rat fetus was divided into 5 groups as follows: negative control; positive control (gp120 1nM); treatment I, II, and III (gp120 1 nM + alpha-pinene 0.4 µg/mL, 2 µg/mL, and 10 µg/mL, respectively). Microglial NF-κB and iNOS expression were analyzed using immunohistochemistry method. Neuronal apoptosis was measured by TUNNEL method.
Results: Result showed that alpha-pinene administration on gp120-treated neuron-glia at all dosages decrease NF-kB activation, iNOS expression, and apoptotic neuron significantly as compared to the gp120-only treated group (p<0.05). Furthermore, alpha-pinene did not affect NF-kB activation and neuronal apoptosis (p>0.05), but significantly elevate iNOS expression (p<0.05) mainly in dosage I and II.
Conclusion: We concluded that alpha-pinene has neuroprotective effect on gp120-treated neuron-glia cells through modulation of NF-kB and iNOS expression thus inhibit neuronal apoptosis.References
Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J. Neurovirol; 2011. 17:3–16. DOI: 10.1007/s13365-010-0006-1
Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nat. Rev. Neurosci; 2007. 8 : 57-69. Avalaible from: https://www.nature.com/articles/nrn2038
Ghafouri M, Amini S, Khalili K and Sawaya BF. HIV-1 associated dementia: symptoms and causes. Retrovirol; 2006. 3:28-35. DOI: 10.1186/1742-4690-3-28
Yadav A, Collman RG. CNS Inflammation and macrophage/microglial biology associated with HIV-1 infection. J Neuroimmune Pharmacol; 2009. 4:430-447. DOI: 10.1007/s11481-009-9174-2
Gao M and Hong JS. Why neurodegenerative diseases are progressive: Uncontrolled inflammation drives disease progression. Trends Immunol; 2008. 29(8): 357-365. DOI: 10.1016/j.it.2008.05.002
Medders KE, Sejbuk NE, Maung R, et al. Activation of p38 MAPK is required in monocytic and neuronal cells for HIV glycoprotein 120-induced neurotoxicity. J Immunol; 2010. 185:4883-4895.
DOI: 10.4049/jimmunol.0902535
Rumbaugh JA, and Nath A. Developments in HIV neuropathogenesis. Current Pharmaceutical Design; 2006. 12:1023-1044.
Brabers NACH and Nottet HSLM. Role of the pro-inflammatory cytokines TNF-a and IL-1β in HIV-associated dementia. European Journal of Clinical Investigation; 2006. 36: 447-458.
DOI: 10.1111/j.1365-2362.2006.01657.x
Dheen ST, Kaur C, Ling E. Microglial activation and its implications in the brain diseases. Current Medicinal Chemistry; 2007. 14:1189-1197. DOI:
Herbein G, Gras G, Khan KA, et al. Macrophage signaling in HIV-1 infection. Retrovirology; 2010. 7: 1-13. Avalaible from:
https://retrovirology.biomedcentral.com/articles/10.1186/1742-4690-7-34
Pande V and Ramos MJ. NF-кB in human disease: current inhibitors and prospect for de novo structure based design of inhibitors. Current Medicinal Chemistry; 2005. 12:357-374.
DOI: 10.2174/0929867053363180
Qin Z, Tao L, Chen X. Dual roles of NF-kB in cell survival and implications of NF-kB inhibitors in
neuroprotective therapy. Acta Pharmacol Sin; 2007. 28 (12): 1859-1872. Avalaible from: https://www.nature.com/articles/aps2007228
Heras B and Hortelano S. Molecular basis of the anti-inflammatory effects of terpenoids. Inflammation & Allergy – Drug Targets; 2009. 8: 28-39 . DOI: 10.2174/187152809787582534
Kalinichenko SG and Matveeva. Morphological Characteristics of Apoptosis and Its Significance in Neurogenesis. Neuroscience and Behavioral Phys 2008; 38(4): 333-344. DOI: 10.1007/s11055-008-0046-7.
Polazzi E and Monti B. Microglia and neuroprotection: From in vitro studies to therapeutic applications. Progress in Neurobiology; 2010. 92: 293-315. DOI: 10.1016/j.pneurobio.2010.06.009
Mercier B, Prost J, Prost M. The essential oil of turpentine and its major volatile fraction (α- and β-pinenes): A review. Journal of Occupational Medicine and Environmental Health; 2009. 22(4):331 – 342. DOI: 10.2478/v10001-009-0032-5
Salminen A, Lehtonen M, Suuronen T et al. Terpenoids: Natural inhibitors of NF-κB signaling with anti-inflammatory and anticancer potential. Cell Mol.Life Sci; 2008. 65:2979-2999.
DOI: 10.1007/s00018-008-8103-5
Lin CT, Chen CJ, Lin TY et al. Anti-inflammation activity of fruit essenstial oil from cinnamomum insularimontanum hayata. Bioresour Technol; 2008. 18:8783-8787. DOI: 10.1016/j.biortech.2008.04.041
Holt FE, Birks TPH, Thorgrimsen LM, Spector AE. et al. Aromatherapy in dementia. The Cochrane Collaboration, Joh Wiley & Sons; 2009. pp. 1-10.
Nesbit CE and Schwartz SA. In vitro and animal models of human immunodeficiency virus infection of the central nervous system. Clin and Diagnostic Lab Immunol; 2002. 9(3): 515-524. DOI: 10.1128/CDLI.9.3.515-524.2002
Jana M, Jana A, Pal U. et al. A simplified method for isolating neuron, oligodendrocytes, astrocytes and microglia from the same human fetal brain tissue. Neurochem Res; 2007. 32(12):2015-2022. DOI: 10.1007/s11064-007-9340-y
Kanmogne GD, Schall K, Leibhart J. et al. HIV-1 gp120 compromises blood barrier integrity and enhance monocyte migration across blood-brain barrier: Implication for viral neuropathogenesis. J.Cereb Blood Flow & Metab; 2007. 27(1):123-134. DOI: DOI: 10.1038/sj.jcbfm.9600330
Ivanenkov YA, Balakin KV, and Tkachenko SE. New approaches to the treatment of inflammatory disease. Drugs RD; 2008. 9(6):397-434.
DOI: 10.2165/0126839-200809060-00005
Saha R and Pahan K. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxidants and Redox Signaling; 2006. 8(5): 929 -947. DOI: 10.1089/ars.2006.8.929
Miguel MG. Antioxidant and anti-inflammatory activities of essenial oils: A short review. Molecules; 2010. 15: 9252-9287. DOI: 10.3390/molecules15129252
Neves A, Rosa S, Goncalves J, et al. Screening of five essential oils for identification of potential inhibitors of il-1-induced nf-κb activation and no production in human chondrocytes: Characterization of the inhibitory activity of alpha-pinene. Planta Med; 2010. 76: 303-308. DOI: 10.1055/s-0029-1186085
Murtyastami K. Kajian efek alfa-pinen terhadap inos pada kultur sel neuron-glia yang dipapar lipopolisakarida [Skripsi]. Jurusan Biologi Fakultas MIPA, Universitas Brawijaya, Malang; 2008.
Jayanti GE. Peranan alpha-pinene terhadap apoptosis neuron [Tesis]. Pascasarjana Universitas Brawijaya Malang; 2010.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Malang Neurology Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
